Reckitt Benckiser Group (RKT)

Sector:

Household Goods

Index:

FTSE 100

4,476.00p
   
  • Change Today:
      7.00p
  • 52 Week High: 6,570.00
  • 52 Week Low: 4,110.00
  • Currency: UK Pounds
  • Shares Issued: 705.35m
  • Volume: 3,319,910
  • Market Cap: £31,572m

Reckitt on track to deliver FY targets as Q1 LFL sales rise

By Michele Maatouk

Date: Wednesday 24 Apr 2024

LONDON (ShareCast) - (Sharecast News) - Consumer goods giant Reckitt Benckiser said on Wednesday that it was on track to deliver its full-year revenue and profit targets as it posted a rise in first-quarter like-for-like net sales.
In an update for the three months to the end of March, the Dettol and Lysol maker said LFL net revenue grew 1.5% to £3.7bn, with a volume decline of 0.5% and price/mix growth of 2%.

The hygiene segment saw LFL net revenue growth of 7.1%, with broad-based volume growth across Finish, Lysol, Harpic and Vanish.

In the health unit, LFL net revenues rose 1%. Reckitt pointed to strong volume growth across Intimate Wellness, non-seasonal over-the-counter brands, VMS and Dettol. This was offset by the expected lapping of prior year retailer inventory rebuild in seasonal OTC products.

In nutrition, however, LFL net revenue fell 9.9%.

Reckitt reiterated its 2024 guidance for LFL net revenue growth of between 2% and 4% for the group. It also continues to expect mid-single-digit growth for the health and hygiene portfolios and a mid to high-single-digit decline for the nutrition business.

Chief executive Kris Licht said: "We have delivered a good first quarter. Following a period of price-led growth, we are now returning to a more balanced contribution from price, mix and volume. We grew volumes in many of our powerbrands in the quarter, including Lysol, Dettol, Durex and Finish, as well as our non-seasonal OTC portfolio.

"In addition, we continue to benefit from carryover pricing and consumers trading up to our premium innovations.

"The net revenue performance in the quarter is in line with our expectations. Hygiene delivered broad-based growth. Health saw good growth across many brands, reduced by a tough comparator in our cold & flu OTC brands. Nutrition continues to normalise in the US as expected, and we have maintained our value market share leadership."

At 1045 BST, the shares were up 5.1% at 4,468p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Reckitt Benckiser Market Data

Currency UK Pounds
Share Price 4,476.00p
Change Today 7.00p
% Change 0.16 %
52 Week High 6,570.00
52 Week Low 4,110.00
Volume 3,319,910
Shares Issued 705.35m
Market Cap £31,572m

Reckitt Benckiser Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.90% above the market average33.90% above the market average33.90% above the market average33.90% above the market average33.90% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
55.76% below the market average55.76% below the market average55.76% below the market average55.76% below the market average55.76% below the market average
46.15% below the sector average46.15% below the sector average46.15% below the sector average46.15% below the sector average46.15% below the sector average
Income
55.28% above the market average55.28% above the market average55.28% above the market average55.28% above the market average55.28% above the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Growth
33.76% above the market average33.76% above the market average33.76% above the market average33.76% above the market average33.76% above the market average
46.15% above the sector average46.15% above the sector average46.15% above the sector average46.15% above the sector average46.15% above the sector average

What The Brokers Say

Strong Buy 5
Buy 4
Neutral 8
Sell 0
Strong Sell 1
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reckitt Benckiser Dividends

  Latest Previous
  Final Interim
Ex-Div 11-Apr-24 03-Aug-23
Paid 24-May-24 15-Sep-23
Amount 115.90p 76.60p

Trades for 03-May-2024

Time Volume / Share Price
17:01 1,320 @ 4,476.27p
17:01 1,316 @ 4,476.27p
17:01 26,279 @ 4,476.27p
17:01 52,645 @ 4,476.27p
16:49 213 @ 4,476.00p

Reckitt Benckiser Key Personnel

Chair Jeremy Darroch
CEO Kris Licht

Top of Page